Q4 2024 Earnings Call Transcript March 31, 2025 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.07. Operator: Good afternoon, ladies and gentleman ...

today raised 2025 pro forma revenue by 30% to more than $65M in the updated investor presentation published on its investor website. The presentation also provides more details on its recently ...

today raised 2025 pro forma revenue by 30% to more than $65M in the updated investor presentation published on its investor website. The presentation also provides more details on its ...